Mark Hlatky, MD

Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health

Academic Appointments

Professor, Health Policy
Professor, Medicine - Cardiovascular Medicine
Professor (By courtesy), Epidemiology and Population Health
Member, Cardiovascular Institute
Member, Stanford Cancer Institute

Administrative Appointments

Chair, Department of Health Research and Policy (1996 - 2003)
Director, Health Services Research Masters Degree Program (1989 - 2019)
Director, Stanford-Kaiser Cardiovascular Outcomes Research Center (2008 - 2013)

Honors & Awards

Outstanding Lifetime Achievement Award, Council on Quality of Care and Outcomes Research, American Heart Association (2014)
Distinguished Scientist Award, American Heart Association (2014)
Distinguished Scientist Award, American College of Cardiology (2015)

Projects

EPOCH Study (Effect of Preeclampsia on Cardiovascular Health), Stanford University School of Medicine, and the Danish National Biobank (Statens Serum Institut)
This project will enroll 3 cohorts of women, and measure biomarkers that may explain the association of preeclampsia early in life with an increased risk of atherosclerotic cardiovascular disease later in life

Location

Stanford University School of Medicine

Collaborators
- Gary Shaw, NICU Nurses Professor and Professor (Research), by courtesy, of Health Research and Policy (Epidemiology) and of Obstetrics and Gynecology (Maternal Fetal Medicine), Stanford University School of Medicine
- Marcia Stefanick, Professor (Research) of Medicine (Stanford Prevention Research Center), of Obstetrics and Gynecology and, by courtesy, of Health Research and Policy (Epidemiology), Stanford
- David Stevenson, Professor, Stanford
- Virginia Winn, Stanford University School of Medicine

Professional Education

BS, MIT, Physics (1972)
MD, University of Pennsylvania, Medicine (1976)

Current Research and Scholarly Interests

Cardiovascular Health Services Research
Cost-Effective Analysis, especially of new technology
Clinical Outome Research
Randomized Clinical Trials with cost, quality of life endpoints (coronary angioplasty, stents, and bypass surgery; diabetes management)
Clinical Guidelines Development
Patient Outcomes Research in Cardiac Arrhythmias

Clinical Trials

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts) Not Recruiting
More
The objective of the PLATFORM Study is to compare clinical outcomes, resource utilization, and quality of life (QOL) of FFRCT-guided evaluation versus standard practice evaluation in patients with suspected CAD in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis of CAD

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- Mark Hlatky, MD
View full details

Find a doctor

Clinics & Services

Research Resources

Professional Training

Education Resources

Mark Hlatky, MD

Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health

Location

Collaborators

Stanford Investigators

2022-23 Courses

2021-22 Courses

Graduate and Fellowship Programs